Chargement des cours...
Prévisions
| Acheter |
1 |
| Conserver |
0 |
| Vendre |
0 |
Actualités Accéder au fil d'actualités
The Cannabist Company sells Virginia business to Curaleaf for $110 million
The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Plus sur de.investing.com
Cannabist Company reports revenue decline and falling EBITDA in Q3 2025
Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Plus sur de.investing.com
Cannabist Company reports revenue decline and share price loss due to restructuring
Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Plus sur de.investing.com
Données financières de l'entreprise
| (EUR) | septembre 2025 | YoY |
|---|---|---|
| Chiffre d'affaires | 68,1 M | - |
| Bénéfice brut | 19,52 M | - |
| Bénéfice net | -12,15 M | - |
| EBITDA | 6,65 M | - |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 12,92 M € |
Nombre d'actions | 497,46 M |
Plus haut/bas sur 52 semaines | 0,14 € - 0,0178 € |
| Dividendes | Non |
Bêta | 1,05 |
Ratio P/E | -0,15 |
Ratio PEG | 0,00 |
Ratio P/B | -0,10 |
Ratio P/S | 0,09 |
Profil de l'entreprise
The Cannabist Company Holdings Inc. exerce ses activités dans la culture, la fabrication et la fourniture de produits à base de cannabis et de services connexes aux États-Unis et à l'international. La société propose des produits comprenant des fleurs, des comestibles, des huiles et des comprimés, sous les marques Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press et Amber. Elle détient des licences dans 17 juridictions aux États-Unis. La société était auparavant connue sous le nom de Columbia Care Inc. et a changé sa dénomination en The Cannabist Company Holdings Inc. en septembre 2023. Fondée en 2012, la société a son siège social à New York, New York.
| Nom | Cannabist Co. Holdings Aktie |
| PDG | Christopher Marr |
| Siège social | Malvern,
pa États-Unis |
| Site web | |
| Introduction en bourse | 29/04/2019 |
| Employés | 2 829 |
Symboles boursiers
| Bourse | Symbole |
|---|---|
Neo | CBST.NE |
Pnk | CBSTF |
Frankfurt | VW5.F |
Düsseldorf | VW5.DU |
München | VW5.MU |